-
Forward Look
Double Mastectomies on the RiseStudy suggests fears rather than actual risk of recurrence drive decisions.
by Cameron Walker
-
Forward Look
Deciphering New Rates of Thyroid CancerExperts are divided on whether the increase is due to more cancer or more diagnoses.
by Melissa Weber
-
First Person
Never Alone: A Family JourneyA mother and daughter exchange thoughts about their “full-family experience” facing an ovarian cancer diagnosis and treatment.
by Mary (Dicey) Jackson Scroggins and Nneka Scroggins
-
Yesterday & Today
Shining a Light60 Minutes journalist Ed Bradley tried to “shine a light in a dark corner” through his work, but he kept his long struggle with chronic lymphocytic leukemia private.
by Brittany Moya del Pino
-
Forward Look
You’ve Got MailAt-home colorectal cancer tests can increase screening rates.
by Cameron Walker
-
Survivor Profile
Knowing Her OptionsWhen Christina McEvoy was diagnosed with stage IV melanoma, she took the reins of her care, traveling more than 600 miles for treatment and returning home to help other melanoma survivors.
by Melissa Davlin
-
Survivor Profile
Brewing a BusinessWhile getting their new coffee business off the ground, John and Pat Curry took John's cancer treatment one step at a time.
by Jen A. Miller
-
Forward Look
African-Americans at Higher Risk for Multiple MyelomaResearchers aim to identify possible reasons.
by Sue Rochman
-
Survivor Profile
Regaining Her BalanceGymnast Shannon Miller's focus and agility helped her capture seven Olympic medals before she was 20. But the most decorated U.S. gymnast in history struggled to overcome the shock of her ovarian cancer diagnosis and treatment.
by Kevin Begos
-
Healthy Habits
Too Sweet?More thumbs down for sugar-sweetened beverages, as study links sugary drinks with endometrial cancer.
by Marci A. Landsmann
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
